NetworkNewsBreaks

MondayApr 20, 2026 3:00 pm

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Appoints Quenton Petersen as CEO, Transitions David Shan to Executive Chairman

Massimo Group (NASDAQ: MAMO) announced the appointment of Quenton Petersen as Chief Executive Officer, effective April 14, 2026, with David Shan transitioning to Executive Chairman while remaining actively involved in the Company’s strategic direction. Petersen, a nine-year veteran of the company, emphasized continued growth across utility vehicles and electric mobility, alongside a disciplined evaluation of opportunities to integrate advanced technologies such as AI-enabled features and expand into applications including facility operations and smart mobility. To view the full press release, visit https://nnw.fm/crlr3 About Massimo Group (NASDAQ: MAMO) Massimo Group is a manufacturer and distributor of powersports products. Headquartered in Texas, the company offers a full lineup of UTVs, ATVs and mini bikes built…

Continue Reading

MondayApr 20, 2026 3:00 pm

NetworkNewsBreaks – Genius Group Limited (NYSE: GNS) Closes $8 Million Registered Direct Offering 

Genius Group (NYSE: GNS) announced the closing of its previously disclosed registered direct offering, raising gross proceeds of approximately $8.0 million through the sale of 21,621,621 ordinary shares (or pre-funded warrants in lieu thereof). The offering was conducted under the Company’s effective shelf registration statement, with D. Boral Capital LLC serving as exclusive placement agent, and proceeds are expected to support the Company’s continued growth as an AI-powered education platform. To view the full press release, visit https://nnw.fm/ldDwQ About Genius Group Limited Genius Group Limited is an education group delivering AI-powered education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100…

Continue Reading

MondayApr 20, 2026 3:00 pm

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach 

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader  Soligenix (NASDAQ: SNGX) is emphasizing the strategic importance of patient-centric drug development, as outlined by CEO Christopher J. Schaber in a Clinical Leader guest column, which explores how reformulating therapies can improve access, adherence, and real-world viability. Drawing on the company’s experience with SGX945, Schaber explains that early clinical trials revealed a disconnect between IV-based delivery and the daily realities of patients with chronic rare diseases, prompting a shift toward a more practical, home-based subcutaneous approach. According to Schaber, operational challenges such as travel burden, treatment scheduling, and patient retention should be…

Continue Reading

MondayApr 20, 2026 2:33 pm

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) to Drill Historic Heap Leach Pads At Santa Fe Project 

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.  ESGold (CSE: ESAU) (OTCQB: ESAUF) announced it will commence sonic core drilling of historic heap leach pads at its Santa Fe Gold Mine Project in Nevada’s Walker Lane, with permits expected shortly and mobilization of a Boart Longyear LS 450 rig to follow. The planned program includes 95 holes totaling 1,740 meters to evaluate potential gold and silver resources from pads associated with historic production of approximately 359,000 ounces of gold and 700,000 ounces of silver, with the company highlighting the potential for low-cost reprocessing to enhance project economics and support future production and cash flow growth.  To view the…

Continue Reading

MondayApr 20, 2026 2:23 pm

NetworkNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) to Drill Historic Heap Leach Pads At Santa Fe Project

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.  Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) announced it will soon commence sonic core drilling of historic heap leach pads at its Santa Fe Gold Mine Project in Nevada’s Walker Lane, with permits expected shortly and mobilization of a Boart Longyear LS 450 rig to follow. The program will include 95 holes totaling 1,740 meters to evaluate potential gold and silver resources from pads that previously supported production of approximately 359,000 ounces of gold and 700,000 ounces of silver, with the company highlighting the potential for low-cost reprocessing to enhance project economics and support its strategy to expand…

Continue Reading

MondayApr 20, 2026 1:13 pm

NetworkNewsBreaks – Channelchek by Noble Highlights Enhanced Group Inc.’s Planned SPAC Merger with A Paradise Acquisition Corp. (NASDAQ: APAD) Amid Evolving Market Dynamics 

Channelchek, a Noble Financial Group platform, highlights a changing investment landscape in 2025, where capital is increasingly rotating toward differentiated growth opportunities beyond crowded sectors. Within this environment, Enhanced Group Inc.—an emerging sports, media, and consumer health company—is pursuing a public market debut through a proposed business combination with A Paradise Acquisition Corp. (NASDAQ: APAD), positioning itself within a more selective and disciplined SPAC market. Channelchek notes that today’s SPAC environment is defined by improved deal structures, stronger sponsor alignment, and heightened investor scrutiny—factors that may benefit companies like Enhanced Ltd (“Enhanced” or the “Company”) as it advances its merger with A Paradise. As investors look…

Continue Reading

MondayApr 20, 2026 9:00 am

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Repurchases 400,000 Shares Under $3 Million Buyback Program

Safe Pro Group (NASDAQ: SPAI) reported continued execution of its share repurchase program, with 400,000 shares repurchased as of April 17, 2026, representing approximately 3.5% of its public float under a $3.0 million authorization approved in December 2025. The company funded repurchases through operating cash flow and its strong balance sheet, which included $16.7 million in cash and no debt at year-end 2025, and said it may continue opportunistic buybacks while investing in its AI-enabled defense and security platform and long-term growth initiatives. To view the full press release, visit https://nnw.fm/T4C4f About Safe Pro Group Inc. Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company…

Continue Reading

FridayApr 17, 2026 2:05 pm

NetworkNewsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Deploys AI, Thermal Imaging to Redefine Rail Safety

Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the industry,” reads a recent article. “Rail Vision’s AI-powered electro-optical sensor systems are designed to address key railway safety challenges by integrating wide-field and narrow-field electro-optic cameras to provide a complete ‘safety envelope’ around the train. The company’s solutions include the use of thermal cameras that…

Continue Reading

FridayApr 17, 2026 1:16 pm

NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. By inhibiting PP2A, the compound stimulates cell-cycle progression and interferes with DNA repair in cancer cells, potentially making tumors more responsive to chemotherapy and immunotherapy. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with significant unmet medical need, including ovarian clear…

Continue Reading

FridayApr 17, 2026 12:35 pm

NetworkNewsBreaks – Suntex Enterprises Inc. (OTC: SNTX) Reports Restructuring Completion and Simplified Capital Structure

Suntex Enterprises (OTC: SNTX) announced the filing of its annual financial statements, highlighting a completed operational restructuring and simplified capital structure with no outstanding debt or convertible instruments. The company also confirmed submission of a corporate action to FINRA seeking approval for a shareholder dividend tied to a diversified portfolio of operating businesses, as Suntex advances a strategy focused on scaling its subsidiaries through organic growth and acquisitions while targeting approximately $100 million in annual revenue and evaluating potential uplisting opportunities. To view the full press release, visit https://nnw.fm/pFJV1 About Suntex Enterprises, Inc. (OTC: SNTX) Suntex Enterprises, Inc. is a diversified…

Continue Reading